AMJEVITA Trademark

Trademark Overview


On Thursday, February 11, 2016, a trademark application was filed for AMJEVITA with the United States Patent and Trademark Office. The USPTO has given the AMJEVITA trademark a serial number of 86904419. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 6, 2020. This trademark is owned by Amgen Inc.. The AMJEVITA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations, substances and biosimilars used for the treatment of bone, joint, intestine, colon, skin, lung, eye, bladder, blood cells, and blood vessel diseases and disorders; pharmaceutical preparations, substances and biosimilars for the treatment of autoimmune and immune system, inflammatory, inflammatory bowel, gastrointestinal, musculoskeletal, dermatological, pulmonary, respiratory, oncological, and ophthalmic diseases and disorders; pharmaceutical preparations, substances and biosimilars used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, acute disc prolapse, inflammatory bowel disease, Crohn's disease, ulcerative colitis, Intestinal Behçet's Disease, chronic pouchitis, small bowel lesions, Hermansky-Pudlak syndrome, psoriasis, psoriasis vulgar...
amjevita

General Information


Serial Number86904419
Word MarkAMJEVITA
Filing DateThursday, February 11, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 6, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 25, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations, substances and biosimilars used for the treatment of bone, joint, intestine, colon, skin, lung, eye, bladder, blood cells, and blood vessel diseases and disorders; pharmaceutical preparations, substances and biosimilars for the treatment of autoimmune and immune system, inflammatory, inflammatory bowel, gastrointestinal, musculoskeletal, dermatological, pulmonary, respiratory, oncological, and ophthalmic diseases and disorders; pharmaceutical preparations, substances and biosimilars used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, acute disc prolapse, inflammatory bowel disease, Crohn's disease, ulcerative colitis, Intestinal Behçet's Disease, chronic pouchitis, small bowel lesions, Hermansky-Pudlak syndrome, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, hidradenitis suppurativa, interstitial cystitis, sleep apnea, sarcoidosis, retinal vascular disorders, uveitis, choroidal neovascularization, Pyoderma Gangrenosum, giant cell arteritis, Netherton syndrome, anaplastic thyroid cancers, asthma, and refractory asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 17, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events


Event DateEvent Description
Monday, January 6, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 6, 2020ABANDONMENT - NO USE STATEMENT FILED
Friday, March 22, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 21, 2019EXTENSION 5 GRANTED
Thursday, March 14, 2019EXTENSION 5 FILED
Wednesday, March 20, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 14, 2019TEAS EXTENSION RECEIVED
Thursday, March 7, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 7, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 23, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 21, 2018EXTENSION 4 GRANTED
Wednesday, November 21, 2018EXTENSION 4 FILED
Wednesday, November 21, 2018TEAS EXTENSION RECEIVED
Friday, June 8, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 6, 2018EXTENSION 3 GRANTED
Wednesday, June 6, 2018EXTENSION 3 FILED
Wednesday, June 6, 2018TEAS EXTENSION RECEIVED
Friday, December 22, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 20, 2017EXTENSION 2 GRANTED
Wednesday, December 20, 2017EXTENSION 2 FILED
Wednesday, December 20, 2017TEAS EXTENSION RECEIVED
Thursday, May 11, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 9, 2017EXTENSION 1 GRANTED
Tuesday, May 9, 2017EXTENSION 1 FILED
Tuesday, May 9, 2017TEAS EXTENSION RECEIVED
Tuesday, December 20, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 25, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 25, 2016PUBLISHED FOR OPPOSITION
Wednesday, October 5, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 20, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 16, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 16, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 16, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, September 10, 2016ASSIGNED TO LIE
Thursday, September 1, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 30, 2016NOTIFICATION OF PRIORITY ACTION E-MAILED
Monday, May 30, 2016PRIORITY ACTION E-MAILED
Monday, May 30, 2016PRIORITY ACTION WRITTEN
Friday, May 27, 2016ASSIGNED TO EXAMINER
Wednesday, February 17, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, February 15, 2016NEW APPLICATION ENTERED IN TRAM